Speciality Medicines Ltd
BSE: 544738
₹208.95
₹-10.95
(-4.98%)
As on 22-May-2026IST
Market cap
₹184 Cr
Revenue (TTM)
₹58 Cr
P/E Ratio
21.3
P/B Ratio
3.1
Div. Yield
0 %
Quality Score
5/10
Growth Score
6/10
Valuation Score
7/10
Momentum Score
UNRATED/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹9 Cr
-
ROE
37.9 %
-
ROCE
34.5 %
-
Industry P/E
159.13
-
EV/EBITDA
20
-
Debt to Equity
0.2
-
Book Value
₹47.3
-
EPS
₹13.4
-
Face value
10
-
Shares outstanding
8,785,796
Years Aggregate
CFO
₹--
EBITDA
₹--
Net Profit
₹--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Speciality Medicines
| -- | -26.6 | -- | -- | -- | -- | -- |
|
BSE Healthcare
| 8.8 | 8.8 | 9.7 | 11.0 | 27.5 | 14.1 | 12.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Speciality Medicines
|
209.0 | 183.6 | 58.3 | 8.6 | -- | 37.9 | 21.3 | 3.1 |
| 1,354.4 | 5,886.6 | 6,020.3 | 132.1 | 3.2 | 6.8 | 52.2 | 3.3 | |
| 43.6 | 19.2 | 25.3 | 0.1 | 0.4 | 2.5 | 168.3 | 4.0 | |
| 26.2 | 32.7 | 12.5 | -3.0 | -90.2 | -2.7 | -- | 0.3 | |
| 18.3 | 25.9 | 49.7 | 4.1 | -- | 29.1 | 6.3 | 1.3 | |
| 41.0 | 25.7 | 4.6 | 0.4 | 1.7 | 4 | 65.9 | 2.6 | |
| 45.7 | 25.0 | 294.6 | 2.1 | 0.9 | 163.8 | 12.2 | 9.8 | |
| 95.0 | 185.5 | 106.8 | 4.8 | -- | 14.9 | 38.7 | 4.9 | |
| 1.8 | 7.1 | 115.9 | 0.4 | 0.6 | 8.9 | 18 | 1.6 | |
| 0.3 | 35.8 | 386.8 | 35.4 | 11.1 | 29.9 | 1 | 0.2 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Speciality Medicines
--
-
Incorporated
2021
-
Chairman
Parth Goyani
-
Managing Director
Parth Goyani
-
Headquarters
Ahmedabad, Gujarat
-
Website
Looking for more details about Speciality Medicines Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Speciality Medicines
What is the current share price of Speciality Medicines Ltd Today?
The share price of Speciality Medicines Ltd is ₹208.95 (BSE) as of 22-May-2026 IST. Speciality Medicines Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Speciality Medicines Ltd?
The P/E ratio of Speciality Medicines Ltd is 21.33 times as on 22-May-2026, a 87 discount to its peers’ median range of 159.13 times.
The P/B ratio of Speciality Medicines Ltd is 3.08 times as on 22-May-2026, a 6 discount to its peers’ median range of 3.26 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2025
|
0.00
|
0.00
|
What is the 52 Week High and Low of Speciality Medicines Ltd?
The 52-week high and low of Speciality Medicines Ltd are Rs 381.20 and Rs 121.10 as of 22-May-2026.
What is the market cap of Speciality Medicines Ltd?
Speciality Medicines Ltd has a market capitalisation of ₹ 184 Cr as on 22-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Speciality Medicines Ltd?
Before investing in Speciality Medicines Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.